Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000309
Filing Date
2025-03-11
Accepted
2025-03-11 16:01:35
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atxs-20241231x10k.htm   iXBRL 10-K 2353117
2 EX-19.1 atxs-20241231xex19d1.htm EX-19.1 87484
3 EX-21.1 atxs-20241231xex21d1.htm EX-21.1 4163
4 EX-23.1 atxs-20241231xex23d1.htm EX-23.1 5631
5 EX-31.1 atxs-20241231xex31d1.htm EX-31.1 9480
6 EX-31.2 atxs-20241231xex31d2.htm EX-31.2 9486
7 EX-32.1 atxs-20241231xex32d1.htm EX-32.1 5400
8 EX-32.2 atxs-20241231xex32d2.htm EX-32.2 5376
9 GRAPHIC atxs-20241231xex19d1001.jpg GRAPHIC 9684
  Complete submission text file 0001410578-25-000309.txt   8509396

Data Files

Seq Description Document Type Size
10 EX-101.SCH atxs-20241231.xsd EX-101.SCH 48687
11 EX-101.CAL atxs-20241231_cal.xml EX-101.CAL 52226
12 EX-101.DEF atxs-20241231_def.xml EX-101.DEF 210780
13 EX-101.LAB atxs-20241231_lab.xml EX-101.LAB 482163
14 EX-101.PRE atxs-20241231_pre.xml EX-101.PRE 355637
87 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20241231x10k_htm.xml XML 1239693
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37467 | Film No.: 25727494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)